D
Dalton is developing an AI-driven platform for drug discovery that utilizes machine learning algorithms to predict molecular interactions and optimize compound selection. This technology addresses the inefficiencies in traditional drug design processes, significantly reducing the time and cost associated with bringing new pharmaceuticals to market.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Dalton is developing an AI-driven platform for drug discovery that utilizes machine learning algorithms to predict molecular interactions and optimize compound selection. This technology addresses the inefficiencies in traditional drug design processes, significantly reducing the time and cost associated with bringing new pharmaceuticals to market.